How is the Xilio Therapeutics Inc today?

The Xilio Therapeutics Inc today is trading in the green, up by 4.55% at 0.69.

How has Xilio Therapeutics Inc performed historically?

The Xilio Therapeutics Inc is currently trading up 4.55% on an intraday basis in the past week the index rose 4.55%. The index has been down -12.66% in the past quarter and fell -24.18% in the past year. You can view this in the overview section.

What is Xilio Therapeutics Inc Annual Net Profit?

Xilio Therapeutics Inc Annual Net Profit rose 23.77% in the last year to $58.24 M. Its sector's average net profit growth for the last fiscal year was -14.05%.

What is Xilio Therapeutics Inc Price to Earning Ratio?

Xilio Therapeutics Inc Price to Earning Ratio is -0.66, which is negative.

What is Xilio Therapeutics Inc Stock Price?

Xilio Therapeutics Inc Stock Price fell 24.18% and underperformed its sector by 179.41% in the past year.

What is Xilio Therapeutics Inc Quarterly Net profit?

Xilio Therapeutics Inc Quarterly Net profit rose 22.89% YoY to $13.26 M. Its sector's average net profit growth YoY for the quarter was -236.06%.

What is Xilio Therapeutics Inc Debt to Equity Ratio?

Xilio Therapeutics Inc Debt to Equity Ratio of 0.46 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is Xilio Therapeutics Inc Return on Equity(ROE)?

Xilio Therapeutics Inc Return on Equity(ROE) for the last financial year was -214.02%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is Xilio Therapeutics Inc Mutual Fund Holding?

Xilio Therapeutics Inc Mutual Fund Holding increased by 0.58% in the last quarter to 4.04.

What is Xilio Therapeutics Inc Institutional Holding?

Xilio Therapeutics Inc Institutional Holding decreased by 4.96% in the last quarter to 28.86.

MARKETS
SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
INDUSTRY : MAJOR PHARMACEUTICALS
XILIO THERAPEUTICS INC

Xilio Therapeutics Inc XNAS: XLO

Xilio Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Xilio Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Xilio Therapeutics Inc
Rating: 1.10641675
Author: Trendlyne DVM scores

about

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

0.69 0.03 (4.55%)

59.41% Fall from 52W High

616.4K

XNAS Volume

XNAS 20 Jun, 2025 4:02 PM (EDT)

Not Eligible

Expensive Valuation

16.2 / 100

Technically Bearish

28.1 / 100

No estimates available

Xilio Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Xilio Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effe...

59.41% Fall from 52W High

SWOT Analysis

Xilio Therapeutics Inc Live Price Chart

Xilio Therapeutics Inc FAQ

How is Xilio Therapeutics Inc today?

Xilio Therapeutics Inc today is trading in the green, and is up by 4.55% at 0.69.

How has Xilio Therapeutics Inc performed historically?

Xilio Therapeutics Inc is currently trading up 4.55% on an intraday basis. In the past week the stock rose 4.55%. stock has been down -12.66% in the past quarter and fell -24.18% in the past year. You can view this in the overview section.